Safety of immunotherapy revisited [1]

Clinical and Experimental Allergy

Volumn 36, Issue 6, 2006, Pages 850-851

  Madsen, F ^a  

^a Allergy and Lung Clinic   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

DISEASE SEVERITY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; INJECTION; LETTER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STANDARDIZATION; TECHNIQUE; UNSPECIFIED SIDE EFFECT;

ALLERGENS; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOTHERAPY; SAFETY;

EID: 33745671908     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02509.x     Document Type: Letter

References (10)

1. Frew AJ. Immunotherapy: how safe is safe? Clin Exp Allergy 2006; 36:251-3.
2. Abramson MJ, Puy RM, Weiner JM. Allergen specific immunotherapy for asthma. The Cochrane Database of Systematic Reviews 2003, Issue 4 Art No: CD001186 DOI: 10 1002/14651858CD001186 2003.
3. Kondro W. Adverse reaction database has minimal information. CMAJ 2005; 173:137.
4. Keogh B, Spiegelhalter D, Bailey A et al. The legacy of Bristol: public disclosure of individual surgeons' results. BMJ 2004; 329:450-4.
5. Malling HJ, Weeke B. Immunotherapy. position paper. Allergy 1993; 14(Suppl.):9-35.
6. Li JT, Lockey RF, Bernstein IL et al. Allergen Immunotherapy: a practice parameter. Ann Allergy Asthma Immunol 2003; 90 (Suppl. 1):1-40.
7. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases". Arerugi 1998; 47:698-704.
8. Winther L, Arnved J, Malling HJ et al. Side-effects of allergen-specific immunotherapy. A prospective multi-centre study. Clin Exp Allergy 2006; 36:254-60.
9. Pellegrino R, Viegi G, Brusasco V et al. Interpretative Strategies for lung function tests. Eur Respir J 2005; 26:948-68.
10. Moreno C, Cuesta-Herranz J, Fernandez-Tavora L et al. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004; 34:527-31.